Evaluating the performance characteristics of different antimicrobial susceptibility testing methodologies for testing susceptibility of gram-negative bacteria to tigecycline

被引:0
作者
Sima Babaei
Mehri Haeili
机构
[1] University of Tabriz,Department of Animal Biology, Faculty of Natural Sciences
来源
BMC Infectious Diseases | / 21卷
关键词
Tigecycline; Broth microdilution; Etest; Agar dilution; Disk diffusion; Gram-negative bacteria;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 137 条
[1]  
Ong CT(2005)Penetration, efflux and intracellular activity of tigecycline in human polymorphonuclear neutrophils (PMNs) J Antimicrob Chemother 56 498-501
[2]  
Babalola CP(2017)Tigecycline treatment in an infant with extensively drug-resistant Acinetobacter baumannii bacteremia Int J Infect Dis 61 23-26
[3]  
Nightingale CH(2014)In vitro activity of tigecycline and comparators against carbapenem-resistant Enterobacteriaceae in Africa–Middle East countries: TEST 2007–2012 J Glob Antimicrob Resist 2 179-182
[4]  
Nicolau DP(2015)Tigecycline activity tested against carbapenem-resistant Enterobacteriaceae from 18 European nations: results from the SENTRY surveillance program (2010–2013) Diagn Microbiol Infect Dis 83 183-186
[5]  
Zeng J(2015)The ribosomal S10 protein is a general target for decreased tigecycline susceptibility Antimicrob Agents Chemother 59 5561-5566
[6]  
Zhang L(2013)The emergence of clinical resistance to tigecycline Int J Antimicrob Agents 41 110-116
[7]  
Gao M(2005)Presence of tetracycline resistance determinants and susceptibility to tigecycline and minocycline Antimicrob Agents Chemother 49 1636-1638
[8]  
Wu J(2007)Tigecycline efflux as a mechanism for nonsusceptibility in Acinetobacter baumannii Antimicrob Agents Chemother 51 2065-2069
[9]  
Wu H(2010)ramR mutations in clinical isolates of Klebsiella pneumoniae with reduced susceptibility to tigecycline Antimicrob Agents Chemother 54 2720-2723
[10]  
Chen J(2018)The rapid emergence of Tigecycline resistance in blaKPC–2 harboring Klebsiella pneumoniae, as mediated in vivo by mutation in tetA during Tigecycline treatment Front Microbiol 9 648-35